It is an agreement committing the ABPI and the PM Society to review regularly how they might align activities of mutual relevance. Examples given in the MoU include events, training, content development and surveys designed to identify common issues and facilitate planning to meet arising needs.
Stephen Whitehead, Chief Executive of the ABPI, said:
"The PM Society reaches out to the operational heart of the UK pharmaceutical and life sciences industries and is a natural partner to promote debate and discussion with the people we serve. The working groups in market access, NHS partnerships and patient engagement, aligned as they are with many of our strategic imperatives, offer particular potential for joint-working. I hope the MoU can help drive forward these partnerships and ultimately help the pharmaceutical industry serve patients more effectively."
Chairman of the PM Society Neil Copping said:
"Since we redefined the Society early last year, we have looked to address members’ needs more effectively in the rapidly changing healthcare environment. Aligning strategic and grass roots level activities by joining forces with the ABPI we aim to open new doors and deliver increased value and benefit to both organisations’ membership. Importantly, it will also avoid duplication on initiatives that are relevant industry-wide and might otherwise have been under discussion by both organisations."
Notes to Editor
The PM Society
The PM Society seeks to promote marketing excellence throughout the healthcare and life science industries, promising to educate, inform and facilitate networking through its various channels – online, print and at live events.
The PM Society was established over 30 years ago, and in 2012 presented a new look, introducing Interest Groups aligned to the current challenges and issues facing today’s marketers – Market Access, Digital, NHS Partnerships, Patient Engagement, Personal Development. Alongside its two highly regarded Award schemes – PM Society Advertising Awards and the Digital Media Awards – these groups are led by experts in the field. The not-for-profit Society is run largely by volunteers with a skeleton staff working to support its growing membership from over 230 companies operating in the UK. To achieve our aims we work closely with media partners, third party suppliers and associations to provide quality content, workshops and learning for members.
PriMe, the PM Society’s flexible modular training programme is developed by the industry for the industry addressing the specific training needs for pharmaceutical marketing and associated life sciences disciplines. Working with The MSI Consultancy, courses run throughout the year and are tailored for those new to marketing, anyone needing a refresher and advanced modules for the more experienced marketer. For more information see the PriMe website.
The ABPI represents innovative research-based biopharmaceutical companies, large, medium and small, leading an exciting new era of biosciences in the UK.
This industry, a major contributor to the economy of the UK, brings life-saving and life-enhancing medicines to patients. ABPI members supply 90 per cent of all medicines used by the NHS, and are researching and developing over two-thirds of the current medicines pipeline, ensuring that the UK remains at the forefront of helping patients prevent and overcome diseases.
The ABPI is recognised by Government as the industry body negotiating on behalf of the branded pharmaceutical industry, for statutory consultation requirements including the pricing scheme for medicines in the UK.
For further information, please contact:
Carys Thomas Ampofo
Tel: 07973 821113